Rimegepant 75 mg Is More Effective Than Nonsteroidal Anti-inflammatory Drugs for the Acute Treatment of Migraine: Post Hoc Analysis of Data From 2 Phase 3 Trials

被引：0
|
作者：
Blumenfeld, A. M. [1 ]
Buse, D. [2 ]
Turner, I. M. [3 ]
Stock, D. A. [4 ]
Morris, B. A. [5 ]
Coric, V [4 ]
Croop, R. [4 ]
机构：
[1] Headache Ctr Southern Calif, Carlsbad, CA USA
[2] Albert Einstein Coll Med, Bronx, NY 10467 USA
[3] Isl Neurol Associates PC, Ctr Headache Care & Res, Plainview, NY USA
[4] Biohaven Pharmaceut, New Haven, CT USA
[5] Biohaven Pharmaceut, New Hven, CT USA
来源：
HEADACHE | 2019年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P246LB
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [1] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Blumenfeld, Andrew
    Buse, Dawn
    Turner, Ira
    Stock, David A.
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2019, 39 : 202 - 202
  • [2] Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-nflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials
    Turner, Ira
    Buse, Dawn
    Blumenfeld, Andrew
    Stock, Elyse
    Stock, David
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
  • [3] Rimegepant 75 mg Demonstrates Superiority to Placebo on Nausea Freedom: Results from a Post Hoc Pooled Analysis of 3 Phase 3 Trials in the Acute Treatment of Migraine
    McAllister, Peter
    Berman, Gary
    Kudrow, David
    Smith, Timothy
    Lipton, Richard
    Stock, Elyse
    Stock, David
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
  • [4] Rimegepant 75 Mg Demonstrates Superiority to Placebo on Nausea Freedom: Results from a Post Hoc Pooled Analysis of 3 Phase 3 Trials in the Acute Treatment of Migraine
    Croop, R.
    Coric, V
    Stock, E. G.
    Stock, D. A.
    Conway, C. M.
    Dubowchik, G. M.
    Jensen, C. M.
    Frost, M.
    Gentile, K.
    Morris, B. A.
    McCormack, T. J.
    Thiry, A. C.
    Forshaw, M.
    Lipton, R. B.
    HEADACHE, 2019, 59 : 51 - 52
  • [5] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Levin, Morris
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charlie
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
  • [6] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Buse, D.
    Blumenfeld, A. M.
    Lipton, R. B.
    Levin, M.
    Thiry, A. C.
    Morris, B. A.
    Coric, V
    Croop, R.
    HEADACHE, 2019, 59 : 175 - 176
  • [7] Rimegepant 75 mg is Effective for the Acute Treatment of Migraine Regardless of Attack Frequency: Results From 3 Phase 3 Trials
    Buse, Dawn
    Blumenfeld, Andrew
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2019, 39 : 187 - 188
  • [8] Rimegepant 75mg Demonstrates Superiority to Placebo on Nausea Freedom: Results from a Post Hoc Pooled Analysis of 3 Phase 3 Trials in the Acute Treatment of Migraine
    McAllister, Peter
    Berman, Gary
    Kudrow, David
    Smith, Timothy
    Croop, Robert
    Coric, Vladimir
    Stock, David A.
    Lipton, Richard
    CEPHALALGIA, 2019, 39 : 206 - 207
  • [9] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Dodick, David W.
    Pavlovic, Jelena M.
    Newman, Lawrence C.
    Lipton, Richard B.
    Thiry, Alexandra
    Morris, Beth A.
    Coric, Vladimir
    Croop, Robert
    CEPHALALGIA, 2019, 39 : 188 - 189
  • [10] Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials
    Pavlovic, Jelena
    Dodick, David
    Newman, Lawrence
    Lipton, Richard
    Stock, Elyse
    Thiry, Alexandra
    Conway, Charles
    Jensen, Christopher
    Morris, Beth
    Coric, Vladimir
    Croop, Robert
    NEUROLOGY, 2020, 94 (15)
12345